Advertisement

Topics

Novartis uses Homology's AMEnDR gene editing platform to develop ophthalmic, blood disorder therapeutics

14:40 EST 14 Nov 2017 | Elsevier Business Intelligence

Novartis AG licensed exclusive worldwide rights to Homology Medicines Inc.'s AMEnDR (AAV-Mediated Editing by Direct Homologou...

Original Article: Novartis uses Homology's AMEnDR gene editing platform to develop ophthalmic, blood disorder therapeutics

NEXT ARTICLE

More From BioPortfolio on "Novartis uses Homology's AMEnDR gene editing platform to develop ophthalmic, blood disorder therapeutics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...